Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

Associate

Evan De Ycaza

Goodwin Procter

main

De Ycaza Evan

Goodwin Associate Evan De Ycaza, from Boston, practices in the firm’s Business Law Department.

Evan De Ycaza

Professional Activities

PROFESSIONAL EXPERIENCE

Credentials

Education

JD2022

BS2017

Certificate of Health Administration and Policy2022

Admissions

Bars

Related Content

Goodwin Advises ProQR on $69.8 Million Underwritten Public Offering Closing and $12.3 Million Concurrent Private Placement

Harpoon Therapeutics To Be Acquired by Merck for $680 Million

EQRx’s Acquisition by Revolution Medicines is Complete

Orchard Therapeutics To Be Acquired By Kyowa Kirin For $387 Million and Contingent Value Rights

EQRx To Be Acquired By Revolution Medicines In All-Stock Transaction

ReNAgade Therapeutics Launches With Over $300 Million in Series A Financing